Advertisement

Management of Mastalgia

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Surgical Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Dixon J.M.
        • Thomas J.
        1 Symptoms, assessment, and guidelines for referral.
        ABC Breast Dis. 2012; : 1
      1. Tahir MT, Shamsudeen S. Mastalgia. InStatPearls [Internet] 2021 Feb 14. StatPearls Publishing.35. D.F. Horrobin (Ed.), Omega-6 Essential Fatty Acids: Pathophysiology and Roles in Clinical Medicine, Wiley-Liss, New York (1990), pp. 20-5384. Yilmaz ED, Deveci E, Kadioglu H, et al. Anxiety and depression levels and personality traits of mastalgia patients. J Psychiatr. 2014; 17–118

        • Mansel R.
        • Webster D.J.
        • Sweetland H.
        Chapter 8: Breast pain and nodularity. Benign Disorders and Diseases of the Breast. Elsevier, 2009: 107-139
        • Ader D.
        • South-Paul J.
        • Adera T.
        • et al.
        Cyclical mastalgia: prevalence and associated health and behavioral factors.
        J Psychosomatic Obstet Gynecol. 2001; 22: 71-76
        • Sasaki J.
        • Geletzke A.
        • Kass R.B.
        • Klimberg S.V.
        • Copeland E.M.
        • Bland K.I.
        • et al.
        Etiology and management of benign breast disease. The Breast.
        The Breast (5th Edition). Elsevier, 2018: 79-92
        • Noroozian M.
        • Stein L.F.
        • Gaetke-Udager K.
        • et al.
        Long-term clinical outcomes in women with breast pain in the absence of additional clinical findings: mammography remains indicated.
        Breast Cancer Res Treat. 2015; 149: 417-424
        • Maddox P.
        • Harrison B.
        • Mansel R.
        • et al.
        Non-cyclical mastalgia: an improved classification and treatment.
        J Br Surg. 1989; 76: 901-904
      2. Evaluation and management of breast pain..
        in: Smith R.L. Pruthi S. Fitzpatrick L.A. Mayo Clinic Proceedings. 79. Elsevier, 2004: 353-372
        • Gumm R.
        • Cunnick G.
        • Mokbel K.
        Evidence for the management of mastalgia.
        Curr Med Res Opin. 2004; 20: 681-684
        • Hubbard T.J.
        • Sharma A.
        • Ferguson D.J.
        Breast pain: assessment, management, and referral criteria.
        Br J Gen Pract. 2020; 70: 419-420
        • Iddon J.
        • Dixon J.M.
        Mastalgia.
        Bmj. 2013; 347
        • Woodworth G.E.
        • Ivie R.M.J.
        • Nelson S.M.
        • et al.
        Perioperative Breast Analgesia: A Qualitative Review of Anatomy and Regional Techniques.
        Reg Anesth pain Med. 2017; 42: 609-631
        • Leung J.W.
        • Kornguth P.J.
        • Gotway M.B.
        Utility of targeted sonography in the evaluation of focal breast pain.
        J Ultrasound Med. 2002; 21: 521-526
        • Harper A.P.
        • Kelly-Fry E.
        • Noe J.S.
        Ultrasound breast imaging-the method of choice for examining the young patient.
        Ultrasound Med Biol. 1981; 7: 231-237
        • Howard M.B.
        • Battaglia T.
        • Prout M.
        • et al.
        The effect of imaging on the clinical management of breast pain.
        J Gen Intern Med. 2012; 27: 817-824
        • Zarei F.
        • Pishdad P.
        • Hatami M.
        • et al.
        Can breast ultrasound reduce patient’s level of anxiety and pain?.
        Ultrasound. 2017; 25: 92-97
        • Hafiz S.P.
        • Barnes N.L.
        • Kirwan C.C.
        Clinical management of idiopathic mastalgia: a systematic review.
        J Prim Health Care. 2018; 10: 312-323
        • Brown N.
        • White J.
        • Brasher A.
        • et al.
        The experience of breast pain (mastalgia) in female runners of the 2012 London Marathon and its effect on exercise behaviour.
        Br J Sports Med. 2014; 48: 320-325
        • Robb G.L.
        • Hortobagyi G.N.
        Advanced therapy of breast disease. PMPH-USA, 2004
        • Brown N.
        • White J.
        • Brasher A.
        • et al.
        An investigation into breast support and sports bra use in female runners of the 2012 London Marathon.
        J Sports Sci. 2014; 32: 801-809
        • Burnett E.
        • White J.
        • Scurr J.
        The Influence of the breast on physical activity participation in females.
        J Phys Activity Health. 2015; 12
        • Brown N.
        • Burnett E.
        • Scurr J.
        Is breast pain greater in active females compared to the general population in the UK?.
        Breast J. 2016; 22: 194-201
        • Wilson M.
        • Sellwood R.
        Therapeutic value of a supporting brassiere in mastodynia.
        Br Med J. 1976; 2: 90
        • Hadi M.S.A.
        Sports brassiere: is it a solution for mastalgia?.
        Breast J. 2000; 6: 407-409
        • White J.
        • Scurr J.
        Evaluation of professional bra fitting criteria for bra selection and fitting in the UK.
        Ergonomics. 2012; 55: 704-711
        • Ambramson D.
        Lateral extra mammary pain syndrome.
        Breast (Edinburgh, Scotland). 1980; 6: 2-5
        • Boneti C.
        • Arentz C.
        • Klimberg V.S.
        Scapulothoracic bursitis as a significant cause of breast and chest wall pain: underrecognized and undertreated.
        Ann Surg Oncol. 2010; 17: 321-324
        • Wisbey J.
        • Mansel R.
        • Pye J.
        • et al.
        Natural history of breast pain.
        Lancet. 1983; 322: 672-674
        • Kataria K.
        • Dhar A.
        • Srivastava A.
        • et al.
        A systematic review of current understanding and management of mastalgia.
        Indian J Surg. 2014; 76: 217-222
        • Davies E.
        • Gateley C.
        • Miers M.
        • et al.
        The long-term course of mastalgia.
        J R Soc Med. 1998; 91: 462-464
        • Kumar S.
        • Rai R.
        • Das V.
        • et al.
        Visual analogue scale for assessing breast nodularity in non-discrete lumpy breasts: The Lucknow–Cardiff breast nodularity scale.
        Breast. 2010; 19: 238-242
        • Fechner R.E.
        Benign breast disease in women on estrogen therapy. A pathologic study.
        Cancer. 1972; 29: 273-279
        • Mauvais-Jarvis P.
        • Sitruk-Ware R.
        • Kuttenn F.
        • et al.
        Luteal phase insufficiency: a common pathophysiologic factor in development of benign and malignant breast diseases.
        Commentaries Res Breast Dis. 1979; 1: 25-59
        • Sitruk-Ware L.
        • Sterkers N.
        • Mowszowicz I.
        • et al.
        Inadequate corpus luteal function in women with benign breast diseases.
        J Clin Endocrinol Metab. 1977; 44: 771-774
      3. Horrobin D.F. Omega-6 Essential Fatty Acids: Pathophysiology and Roles in Clinical Medicine. Wiley-Liss, New York1990: 20-53
        • Cole E.
        • Sellwood R.
        • England P.
        • et al.
        Serum prolactin concentrations in benign breast disease throughout the menstrual cycle.
        Eur J Cancer (1965). 1977; 13: 597-603
        • Preece P.
        • Richards A.
        • Owen G.
        • et al.
        Mastalgia and total body water.
        Br Med J. 1975; 4: 498-500
        • Kumar S.
        • Mansel R.
        • Scanlon M.
        • et al.
        Altered responses of prolactin, luteinizing hormone and follicle stimulating hormone secretion to thyrotrophin releasing hormone/gonadotrophin releasing hormone stimulation in cyclical mastalgia.
        Br J Surg. 1984; 71: 870-873
        • Brennan M.
        • Bulbrook R.
        • Deshpande N.
        • et al.
        Urinary and plasma androgens in benign breast disease: Possible relation to breast cancer.
        Lancet. 1973; 301: 1076-1079
        • Malarkey W.B.
        • Schroeder L.
        • Stevens V.
        • et al.
        Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease.
        Cancer Res. 1977; 37: 4655-4659
        • Watt-Boolsen S.
        • Andersen A.
        • Blichert-Toft M.
        Serum prolactin and oestradiol levels in women with cyclical mastalgia.
        Horm Metab Res. 1981; 13: 700-702
        • Walsh P.V.
        • McDicken I.W.
        • Bulbrook R.D.
        • et al.
        Serum oestradiol-17β and prolactin concentrations during the luteal phase in women with benign breast disease.
        Eur J Cancer Clin Oncol. 1984; 20: 1345-1351
        • Golinger R.
        • Krebs J.
        • Fisher E.
        • et al.
        Hormones and the pathophysiology of fibrocystic mastopathy: elevated luteinizing hormone levels.
        Surgery. 1978; 84: 212-215
        • Kumar S.
        • Mansel R.
        • Wilson D.
        • et al.
        Daily salivary progesterone levels in cyclical mastalgia patients and their controls.
        Br J Surg. 1986; 73: 260-263
        • Sitruk-Ware R.
        • Sterkers N.
        • Mauvais-Jarvis P.
        Benign breast disease I: hormonal investigation.
        Obstet Gynecol. 1979; 53: 457-460
        • Ayers J.W.
        • Gidwani G.P.
        The “luteal breast”: hormonal and sonographic investigation of benign breast disease in patients with cyclic mastalgia.
        Fertil sterility. 1983; 40: 779-784
        • Walsh P.V.
        • Bulbrook R.D.
        • Stell P.M.
        • et al.
        Serum progesterone concentration during the luteal phase in women with benign breast disease.
        Eur J Cancer Clin Oncol. 1984; 20: 1339-1343
        • England P.
        • Skinner L.
        • Cottrell K.
        • et al.
        Sex hormones in breast disease.
        J Br Surg. 1975; 62: 806-809
        • Peters F.
        • Pickardt C.
        • Zimmermann G.
        • et al.
        PRL, TSH, and thyroid hormones in benign breast diseases.
        Klinische Wochenschrift. 1981; 59: 403-407
        • Rea N.
        • Bove F.
        • Gentile A.
        • et al.
        Prolactin response to thyrotropin-releasing hormone as a guideline for cyclical mastalgia treatment.
        Minerva Med. 1997; 88: 479-487
        • Rosolowich V.
        • Saettler E.
        • Szuck B.
        • et al.
        Mastalgia J Obstet Gynaecol Can. 2006; 28: 49-57
        • Minton J.P.
        Dietary factors in benign breast disease.
        Cancer Bull. 1988; 40: 44
        • Bär H.-P.
        Epinephrine-and prostaglandin-sensitive adenyl cyclase in mammary gland.
        Biochim Biophys Acta (BBA)-Enzymology. 1973; 321: 397-406
        • Minton J.P.
        • Abou-Issa H.
        Nonendocrine theories of the etiology of benign breast disease.
        World J Surg. 1989; 13: 680-684
        • Minton J.
        • Foecking M.
        • Webster D.
        • et al.
        Response of fibrocystic disease to caffeine withdrawal and correlation of cyclic nucleotides with breast disease.
        Am J Obstet Gynecol. 1979; 135: 157-158
        • Minton J.
        • Abou-Issa H.
        • Reiches N.
        • et al.
        Clinical and biochemical studies on methylxanthine-related fibrocystic breast disease.
        Surgery. 1981; 90: 299-304
        • Ernster V.L.
        • Mason L.
        • Goodson W.H.
        • et al.
        Effects of caffeine-free diet on benign breast disease: a randomized trial.
        Surgery. 1982; 91: 263-267
        • Allen S.S.
        • Froberg D.G.
        The effect of decreased caffeine consumption on benign proliferative breast disease: a randomized clinical trial.
        Surgery. 1987; 101: 720-730
        • Parazzini F.
        • La Vecchia C.
        • Riundi R.
        • et al.
        Methylxanthine, alcohol-free diet and fibrocystic breast disease: a factorial clinical trial.
        Surgery. 1986; 99: 576-581
        • Ingram D.
        • Hickling C.
        • West L.
        • et al.
        A double-blind randomized controlled trial of isoflavones in the treatment of cyclical mastalgia.
        The Breast. 2002; 11: 170-174
        • Fleming R.
        What effect, if any, does soy protein have on breast tissue?.
        Integr Cancer therapies. 2003; 2: 225-228
        • McFadyen I.
        • Chetty U.
        • Setchell K.
        • et al.
        A randomized double blind-cross over trial of soya protein for the treatment of cyclical breast pain.
        Breast. 2000; 9: 271-276
        • Goodwin P.J.
        • Miller A.
        • Del Giudice M.E.
        • et al.
        Elevated high-density lipoprotein cholesterol and dietary fat intake in women with cyclic mastopathy.
        Am J Obstet Gynecol. 1998; 179: 430-437
        • Boyd N.
        • Shannon P.
        • Kriukov V.
        • et al.
        Effect of a low-fat high-carbohydrate diet on symptoms of cyclical mastopathy.
        Lancet. 1988; 332: 128-132
        • Horrobin D.
        The effects of gamma-linolenic acid on breast pain and diabetic neuropathy: possible non-eicosanoid mechanisms.
        Prostaglandins, Leukot Essent fatty Acids. 1993; 48: 101-104
        • Rose D.P.
        • Boyar A.P.
        • Cohen C.
        • et al.
        Effect of a low-fat diet on hormone levels in women with cystic breast disease. I. Serum steroids and gonadotropins.
        J Natl Cancer Inst. 1987; 78: 623-626
        • Sharma A.
        • Mishra S.
        • Salila M.
        • et al.
        Cyclical mastalgia--is it a manifestation of aberration in lipid metabolism?.
        Indian J Physiol Pharmacol. 1994; 38: 267-271
        • Goyal A.
        • Mansel R.
        on behalf of the Efamast Study Group. A Randomized multicenter study of gamolenic acid (Efamast) with and without antioxidant vitamins and minerals in the management of mastalgia.
        Breast J. 2005; 11: 41-47
        • Ernster V.
        • Goodson 3rd, W.
        • Hunt T.
        • et al.
        Vitamin E and benign breast" disease": a double-blind, randomized clinical trial.
        Surgery. 1985; 97: 490-494
        • Meyer E.
        • Sommers D.
        • Reitz C.
        • et al.
        Vitamin E and benign breast disease.
        Surgery. 1990; 107: 549-551
        • London R.S.
        • Sundaram G.
        • Murphy L.
        • et al.
        The effect of vitamin E on mammary dysplasia: a double-blind study.
        Obstet Gynecol. 1985; 65: 104-106
        • Smallwood J.
        • Ah-Kye D.
        • Taylor I.
        Vitamin B6 in the treatment of pre-menstrual mastalgia.
        Br J Clin Pract. 1986; 40: 532-533
        • McFayden I.
        • Forrest A.
        • Chetty U.
        • et al.
        Cyclical breast pain--some observations and the difficulties in treatment.
        Br J Clin Pract. 1992; 46: 161-164
        • Wetzig N.R.
        Mastalgia: a 3 year Australian study.
        Aust New Zealand J Surg. 1994; 64: 329-331
        • Pye J.
        • Mansel R.
        • Hughes L.
        Clinical experience of drug treatments for mastalgia.
        Lancet. 1985; 326: 373-377
        • Band P.R.
        • Deschamps M.
        • Falardeau M.
        • et al.
        Treatment of benign breast disease with vitamin A.
        Prev Med. 1984; 13: 549-554
        • Brocq P.
        • Stora C.
        • Bernheim L.
        De l’emploi de la vitamine A dans le traitement des mastoses.
        Ann Endocrinol. 1956; 17: 193-200
        • Ghent W.
        • Eskin B.
        • Low D.
        • et al.
        Iodine replacement in fibrocystic disease of the breast.
        Can J Surg J canadien de chirurgie. 1993; 36: 453-460
        • Eskin B.
        • Krouse T.
        • Modhera P.
        • et al.
        Etiology of mammary gland pathophysiology induced by iodine deficiency.
        Front thyroidology. 1986; 2
        • Kessler J.H.
        The effect of supraphysiologic levels of iodine on patients with cyclic mastalgia.
        Breast J. 2004; 10: 328-336
        • Wang J.
        • Zhang H.
        • Allen R.D.
        Overexpression of an Arabidopsis peroxisomal ascorbate peroxidase gene in tobacco increases protection against oxidative stress.
        Plant Cell Physiol. 1999; 40: 725-732
        • Gong C.
        • Song E.
        • Jia W.
        • et al.
        A double-blind randomized controlled trial of toremifen therapy for mastalgia.
        Arch Surg. 2006; 141: 43-47
        • Preece P.
        • Mansel R.
        • Hughes L.
        Mastalgia: psychoneurosis or organic disease?.
        Br Med J. 1978; 1: 29-30
        • Yilmaz E.D.
        • Deveci E.
        • Kadioglu H.
        • et al.
        Anxiety and depression levels and personality traits of mastalgia patients.
        J Psychiatr. 2014; 17: 118
        • Ramirez A.-J.
        • Jarrett S.R.
        • Hamed H.
        • Smith P.
        • Fentiman I.P.
        • et al.
        Psychosocial distress associated with severe mastalgia..
        Recent developments in the study of benign breast disease. Parthenon Publishing Group LTD, 1994: 1019-1116
        • Ramirez A.-J.
        • Jarrett S.
        • Hamed H.
        • et al.
        Psychosocial adjustment of women with mastalgia.
        Breast. 1995; 4: 48-51
        • Groen J.-W.
        • Grosfeld S.
        • Bramer W.M.
        • et al.
        Cyclic and non-cyclic breast-pain: A systematic review on pain reduction, side effects, and quality of life for various treatments.
        Eur J Obstet Gynecol Reprod Biol. 2017; 219: 74-93
        • Barros A.C.S.
        • Mottola Jr., J.
        • Ruiz C.A.
        • et al.
        Reassurance in the treatment of mastalgia.
        Breast J. 1999; 5: 162-165
        • Fox H.
        • Walker L.
        • Heys S.
        • et al.
        Are patients with mastalgia anxious, and does relaxation therapy help?.
        Breast. 1997; 6: 138-142
        • Ngô C.
        • Seror J.
        • Chabbert-Buffet N.
        Breast pain: Recommendations.
        J de gynecologie, obstetrique biologie de la Reprod. 2015; 44: 938-946
        • Wewers M.E.
        • Lowe N.K.
        A critical review of visual analogue scales in the measurement of clinical phenomena.
        Res Nurs Health. 1990; 13: 227-236
        • Colak T.
        • Ipek T.
        • Kanik A.
        • et al.
        Efficacy of topical nonsteroidal antiinflammatory drugs in mastalgia treatment.
        J Am Coll Surgeons. 2003; 196: 525-530
        • Irving A.
        • Morrison S.
        Effectiveness of topical non-steroidal anti-inflammatory drugs in the management of breast pain.
        J R Coll Surgeons Edinb. 1998; 43: 158-159
        • Kaviani A.
        • Mehrdad N.
        • Najafi M.
        • et al.
        Comparison of naproxen with placebo for the management of noncyclical breast pain: a randomized, double-blind, controlled trial.
        World J Surg. 2008; 32: 2464-2470
        • Gateley C.
        • Maddox P.
        • Pritchard G.
        • et al.
        Plasma fatty acid profiles in benign breast disorders.
        J Br Surg. 1992; 79: 407-409
        • Gateley C.
        • Miers M.
        • Mansel R.
        • et al.
        Drug treatments for mastalgia: 17 years experience in the Cardiff Mastalgia Clinic.
        J R Soc Med. 1992; 85: 12
        • Goyal A.
        • Mansel R.E.
        A randomized multicenter study of gamolenic acid (Efamast) with and without antioxidant vitamins and minerals in the management of mastalgia.
        Breast J. 2005; 11: 41-47
        • Srivastava A.
        • Mansel R.
        • Arvind N.
        • et al.
        Evidence-based management of Mastalgia: a meta-analysis of randomised trials.
        The Breast. 2007; 16: 503-512
        • Blommers J.
        • de Lange-de Klerk E.S.
        • Kuik D.J.
        • et al.
        Evening primrose oil and fish oil for severe chronic astalgia: a randomized, double-blind, controlled trial.
        Am J Obstet Gynecol. 2002; 187: 1389-1394
        • Pruthi S.
        • Wahner-Roedler D.L.
        • Torkelson C.J.
        • et al.
        Vitamin E and evening primrose oil for management of cyclical mastalgia: a randomized pilot study.
        Altern Med Rev. 2010; 15: 59
        • Mirghafourvand M.
        • Mohammad-Alizadeh-Charandabi S.
        • Ahmadpour P.
        • et al.
        Effects of Vitex agnus and Flaxseed on cyclic mastalgia: A randomized controlled trial.
        Complement therapies Med. 2016; 24: 90-95
        • Schellenberg R.
        Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study.
        Bmj. 2001; 322: 134-137
        • Halaska M.
        • Beles P.
        • Gorkow C.
        • et al.
        Treatment of cyclical mastalgia with a solution containing a Vitex agnus castus extract: results of a placebo-controlled double-blind study.
        Breast. 1999; 8: 175-181
        • Dukes M.
        Ginseng and mastalgia.
        Br Med J. 1978; 1: 1621
        • Nocerino E.
        • Amato M.
        • Izzo A.A.
        The aphrodisiac and adaptogenic properties of ginseng.
        Fitoterapia. 2000; 71: S1-S5
        • Cupceancu B.
        Short-term tamoxifen treatment in benign breast diseases.
        Endocrinologie. 1985; 23: 169-177
        • Fentiman I.
        • Brame K.
        • Caleffi M.
        • et al.
        Double-blind controlled trial of tamoxifen therapy for mastalgia.
        Lancet. 1986; 327: 287-288
        • Fentiman I.
        • Caleffi M.
        • Hamed H.
        • et al.
        Dosage and duration of tamoxifen treatment for mastalgia: a controlled trial.
        Br J Surg. 1988; 75: 845-846
        • Fentiman I.
        • Caleffi M.
        • Hamed H.
        • et al.
        Studies of tamoxifen in women with mastalgia.
        Br J Clin Pract Suppl. 1989; 68: 34-53
        • Faiz O.
        • Fentiman I.
        Management of breast pain.
        Int J Clin Pract. 2000; 54: 228-232
        • Semiglazov V.
        Tamoxifen therapy for cyclical mastalgia: dose randomized trial.
        The Breast. 1997; 6: 212-213
        • Fisher B.
        • Dignam J.
        • Bryant J.
        • et al.
        Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors.
        JNCI: J Natl Cancer Inst. 1996; 88: 1529-1542
        • Millet A.V.
        • Leal A.
        • Dirbas F.M.
        Clinical management of breast pain..
        Breast Surgical Techniques and Interdisciplinary management. Springer, New York, NY2010: 147-153
        • Oksa S.
        • Luukkaala T.
        • Mäenpää J.
        Toremifene for premenstrual mastalgia: a randomised, placebo-controlled crossover study.
        BJOG: An Int J Obstet Gynaecol. 2006; 113: 713-718
        • Mansel R.
        • Goyal A.
        • Nestour E.L.
        • et al.
        A phase II trial of Afimoxifene (4-hydroxytamoxifen gel) for cyclical mastalgia in premenopausal women.
        Breast Cancer Res Treat. 2007; 106: 389-397
        • Fentiman I.
        • Powles T.
        Tamoxifen and benign breast problems.
        Lancet. 1987; 330: 1070-1072
        • Uzan S.
        • Denis C.
        • Pomi V.
        • et al.
        Double-blind trial of promegestone (R 5020) and lynestrenol in the treatment of benign breast disease.
        Eur J Obstet Gynecol Reprod Biol. 1992; 43: 219-227
        • Colin C.
        • Gaspard U.
        • Lambotte R.
        Relationship of mastodynia with its endocrine environment and treatment in a double blind trial with lynestrenol.
        Archiv für Gynäkologie. 1978; 225: 7-13
        • Maddox P.R.
        • Harrison B.
        • Horobin J.
        • et al.
        A randomised controlled trial of medroxyprogesterone acetate in mastalgia.
        Ann R Coll Surg Engl. 1990; 72: 71
        • Greenblatt R.B.
        • Dmowski W.
        • Mahesh V.
        • et al.
        Clinical studies with an antigonadotropin-danazol.
        Fertil Sterility. 1971; 22: 102-112
        • Chambers C.
        • Arsch R.
        • Panerstein C.
        Danazol binding and translocation of steroids receptors.
        Am J Obstet Gynecol. 1980; 136: 426
        • O'Brien P.S.
        • Abukhalil I.
        Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase–only danazol.
        Am J Obstet Gynecol. 1999; 180: 18-23
        • Sutton G.
        • O'Malley V.
        Treatment of cyclical mastalgia with low dose short term danazol.
        Br J Clin Pract. 1986; 40: 68-70
        • Asch R.H.
        • Greenblatt R.B.
        The use of an impeded androgen—danazol—in the management of benign breast disorders.
        Am J Obstet Gynecol. 1977; 127: 130-134
        • Mansel R.
        • Wisbey J.
        • Hughes L.
        Controlled trial of the antigonadotropin danazol in painful nodular benign breast disease.
        Lancet. 1982; 319: 928-930
        • Snyder B.W.
        • Beecham G.D.
        • Winneker R.C.
        Studies on the mechanism of action of danazol and gestrinone (R2323) in the rat: evidence for a masked estrogen component.
        Fertil sterility. 1989; 51: 705-710
        • Peters F.
        • Brandl E.
        • Tykal P.
        • et al.
        Multicentre study of gestrinone in cyclical breast pain FRIEDOLF PETERS.
        Lancet. 1992; 339: 205-208
        • Mansel R.
        • Preece P.
        • Hughes L.
        A double blind trial of the prolactin inhibitor bromocriptine in painful benign breast disease.
        Br J Surg. 1978; 65: 724-727
        • Hinton C.
        • Bishop H.
        • Holliday H.
        • et al.
        A double-blind controlled trial of danazol and bromocriptine in the management of severe cyclical breast pain.
        Br J Clin Pract. 1986; 40: 326-330
        • Arrowsmith-Lowe T.
        Bromocriptine indications withdrawn.
        FDA Med Bull. 1994; 24
        • Aydin Y.
        • Atis A.
        • Kaleli S.
        • et al.
        Cabergoline versus bromocriptine for symptomatic treatment of premenstrual mastalgia: a randomised, open-label study.
        Eur J Obstet Gynecol Reprod Biol. 2010; 150: 203-206
        • Chan J.
        Magic for mastalgia with HT7.
        Acupuncture Med. 2015; 33: 82
        • Thicke L.A.
        • Hazelton J.K.
        • Bauer B.A.
        • et al.
        Acupuncture for treatment of noncyclic breast pain: a pilot study.
        Am J Chin Med. 2011; 39: 1117-1129
        • Gregory W.
        • Mills S.
        • Hamed H.
        • et al.
        Applied kinesiology for treatment of women with mastalgia.
        Breast. 2001; 10: 15-19